The estimated Net Worth of Bradley Paul Morgan is at least $2.64 Milione dollars as of 31 August 2017. Bradley Morgan owns over 118,330 units of Cytokinetics Inc stock worth over $2,638,978 and over the last 19 years Bradley sold CYTK stock worth over $0.
Bradley has made over 1 trades of the Cytokinetics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Bradley exercised 118,330 units of CYTK stock worth $927,707 on 31 August 2017.
The largest trade Bradley's ever made was exercising 118,330 units of Cytokinetics Inc stock on 31 August 2017 worth over $927,707. On average, Bradley trades about 39,443 units every 0 days since 2006. As of 31 August 2017 Bradley still owns at least 49,079 units of Cytokinetics Inc stock.
You can see the complete history of Bradley Morgan stock trades at the bottom of the page.
Bradley's mailing address filed with the SEC is 280, East Grand Avenue, South San Francisco, San Mateo County, California, 94080, United States.
Over the last 20 years, insiders at Cytokinetics Inc have traded over $50,353,277 worth of Cytokinetics Inc stock and bought 879,922 units worth $7,454,506 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Capital Ltd Portfolio Servi... e Partners L P/Ilbiotechnolog.... On average, Cytokinetics Inc executives and independent directors trade stock every 14 days with the average trade being worth of $1,225,580. The most recent stock trade was executed by B Lynne Parshall on 9 September 2024, trading 5,000 units of CYTK stock currently worth $108,050.
cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.
Cytokinetics Inc executives and other stock owners filed with the SEC include: